Entity
  • Defymed

    Created in 2011
  • BETA

    Up & running (A)
    Existing signals show a regular activity
  • Social networks

    4,610
  • Activities

  • Technologies

  • Entity types

  • Location

    9 Rue Albert Calmette, 67200 Strasbourg, France

    Strasbourg

    France

  • Employees

    Scale: 11-50

    Estimated: 4

  • SIREN

    530643030
  • Engaged corporates

    18
    0 18
  • Added in Motherbase

    4 years, 4 months ago
Description
  • Value proposition

    Advanced therapies inspired for you

    Defymed is a French SME that develops innovative medical devices aimed at treating patients physiologically in order to improve the clinical effectiveness of their treatment as well as their comfort. Defymed is a spin-off of the Centre européen d’étude du Diabète (European center for diabetes studies), which began work on a bioartificial pancreas in 1996. Today, Defymed focuses on diabetes, which is considered to be one of the major epidemics of the 21st century.
    There are currently two medical devices being developed by Defymed which are at an advanced preclinical trial phase:
    - #MailPan®: bioartificial pancreas
    - #ExOlin®: physiological insulin delivery device

    Bioartificial Pancreas, Medical Devices, Bioartificial Organs, Cell encapsulation, MailPan®, ExOlin®, Insulin delivery device, Cell therapy, and Diabetes

  • Original language

    Advanced therapies inspired for you

    Defymed is a French SME that develops innovative medical devices aimed at treating patients physiologically in order to improve the clinical effectiveness of their treatment as well as their comfort. Defymed is a spin-off of the Centre européen d’étude du Diabète (European center for diabetes studies), which began work on a bioartificial pancreas in 1996. Today, Defymed focuses on diabetes, which is considered to be one of the major epidemics of the 21st century.
    There are currently two medical devices being developed by Defymed which are at an advanced preclinical trial phase:
    - MailPan®: bioartificial pancreas
    - ExOlin®: physiological insulin delivery device

Corporate interactions BETA
Corporate TypeTweets Articles
Lyonbiopôle Auvergne-Rhône-Alpes
Lyonbiopôle Auvergne-Rhône-Alpes
Public business cluster, Biotechnology, French Cluster, Biotechnology Research
Lyonbiopôle Auvergne-Rhône-Alpes
Public business cluster, Biotechnology, French Cluster, Biotechnology Research
Other

31 May 2023


United Nations Academic Impact
United Nations Academic Impact
International development, International Affairs
United Nations Academic Impact
International development, International Affairs
Other

22 Mar 2023


European Parliament
European Parliament
European Union, Political Organizations
European Parliament
European Union, Political Organizations
Other

14 Jan 2023


Ville et Eurométropole de Strasbourg
Ville et Eurométropole de Strasbourg
National and local authorities, Government Administration, French metropolis
Ville et Eurométropole de Strasbourg
National and local authorities, Government Administration, French metropolis
Not capitalistic
Partnership
Event

19 Jan 2023


La Tribune
La Tribune
Media, Newspapers
La Tribune
Media, Newspapers
Not capitalistic
Not partnership
Event

5 Apr 2023


Medtronic
Medtronic
Pharmaceutical, Medical Equipment Manufacturing
Medtronic
Pharmaceutical, Medical Equipment Manufacturing
Other

14 Nov 2022


Business France
Business France
National and local authorities, Government Administration
Business France
National and local authorities, Government Administration
Not capitalistic
Partnership
Not event

31 May 2022


European Commission
European Commission
European Union, Environmental Services
European Commission
European Union, Environmental Services
Capitalistic
Partnership
Not event

14 Jan 2023


Bpifrance
Bpifrance
Bank, Banking
Bpifrance
Bank, Banking
Not capitalistic
Partnership
Event

8 Mar 2023


CCI GRAND EST
CCI GRAND EST
Chamber of commerce, Government Administration
CCI GRAND EST
Chamber of commerce, Government Administration
Other

12 Apr 2023


Similar entities
Loading...
Loading...
Social network dynamics